Skip to content

Oral intervention combined with standard quadruple therapy for Helicobacter pylori infection: a randomized controlled clinical study

Oral intervention combined with standard quadruple therapy for Helicobacter pylori infection: a randomized controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029246
Enrollment
Unknown
Registered
2020-01-20
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Individualized treatment for Helicobacter pylori infection in Jiangsu Province

Interventions

Group 1:quadruple therapy
Group 2:toothwash combined with triple therapy
Group 3:toothwash combined with quadruple therapy

Sponsors

Jiangsu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 ~ 70 years old, male or female; 2. visit the doctor for discomfort symptoms such as abdominal pain, abdominal distension, regurgitation, belching, nausea, vomiting, heartburn, chest pain, etc.; 3. no antibiotics, bismuth, H2 receptor antagonist or PPI preparation were given within the last 4 weeks; 4. positive 13C urea breath test; 5. agree to perform gastroscopy and take gastric mucosa biopsy specimens for HP culture, drug sensitivity test and other experiments related to this study; 6. HP infected patients who agree to the eradication treatment of HP, and are willing to cooperate with doctors to conduct follow-up investigation on the efficacy of eradication; 7. sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. patients who failed to eradicate helicobacter pylori treatment; 2. patients with contraindicated gastric mucosal biopsy (coagulation dysfunction, taking anticoagulant drugs, etc.); 3. serious impairment of heart, liver and kidney function; 4. pregnant or lactating women; 5. hematemesis, black stool, perforation, pyloric obstruction, cancer complications; 6. patients with a history of esophageal and gastrointestinal surgery; 7. patients who cannot properly express their main complaints, such as mental illness or severe neurosis; 8. those who take nonsteroidal anti-inflammatory drugs or alcohol at the same time; 9. allergic to any of the 6 antibiotics (amoxicillin, metronidazole, clarithromycin, levofloxacin, tetracycline, furazolidone) in the HP drug sensitivity test.

Design outcomes

Primary

MeasureTime frame
13C breath test;oral cell;

Countries

China

Contacts

Public ContactZhang Guoxin

Department of Gastroenterology, the First Affiliated Hospital of Nanjing Medical University

1044450463@qq.com+86 13951913128

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026